200 related articles for article (PubMed ID: 35239557)
1. Recognizing New-Onset Sleep Disorders in Autoimmune Encephalitis Often Prompt Earlier Diagnosis.
Ralls F; Cutchen L; Grigg-Damberger MM
J Clin Neurophysiol; 2022 Jul; 39(5):363-371. PubMed ID: 35239557
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune sleep disorders.
Silber MH
Handb Clin Neurol; 2016; 133():317-26. PubMed ID: 27112685
[TBL] [Abstract][Full Text] [Related]
3. Sleep disturbances are common in patients with autoimmune encephalitis.
Blattner MS; de Bruin GS; Bucelli RC; Day GS
J Neurol; 2019 Apr; 266(4):1007-1015. PubMed ID: 30741377
[TBL] [Abstract][Full Text] [Related]
4. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
Li Y; Jia Y
Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
[TBL] [Abstract][Full Text] [Related]
5. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis.
Erkent I; Elibol B; Saka E; Saygi S; Tezer I
Neurol Sci; 2023 Apr; 44(4):1351-1360. PubMed ID: 36454441
[TBL] [Abstract][Full Text] [Related]
6. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.
Sabater L; Gaig C; Gelpi E; Bataller L; Lewerenz J; Torres-Vega E; Contreras A; Giometto B; Compta Y; Embid C; Vilaseca I; Iranzo A; Santamaría J; Dalmau J; Graus F
Lancet Neurol; 2014 Jun; 13(6):575-86. PubMed ID: 24703753
[TBL] [Abstract][Full Text] [Related]
7. Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.
Lin N; Hao H; Guan H; Sun H; Liu Q; Lu Q; Jin L; Ren H; Huang Y
Front Neurol; 2020; 11():696. PubMed ID: 32849186
[No Abstract] [Full Text] [Related]
8. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
9. [Anti-voltage-gated potassium channel (VGKC) complex/leucine-rich glioma-inactivated protein 1 (LGI1) antibody-associated limbic encephalitis mimicking dementia with Lewy bodies in a patient with subacute REM sleep behavior disorder].
Arakawa I; Oguri T; Nakamura T; Sakurai K; Yuasa H
Rinsho Shinkeigaku; 2022 Jan; 62(1):22-26. PubMed ID: 34924467
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of anti-IgLON5 disease].
Shimohata T; Kimura A
Rinsho Shinkeigaku; 2021 Dec; 61(12):825-832. PubMed ID: 34789633
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Chung HY; Wickel J; Voss A; Ceanga M; Sell J; Witte OW; Geis C
Medicine (Baltimore); 2019 May; 98(20):e15706. PubMed ID: 31096519
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcomes of leucine-rich glioma-inactivated protein 1 and contactin protein-like 2 antibody-associated autoimmune encephalitis in a Chinese cohort.
Li HY; Qiao S; Cui CS; Feng F; Liu XW; Yang XD
J Clin Neurosci; 2022 Jul; 101():137-143. PubMed ID: 35597061
[TBL] [Abstract][Full Text] [Related]
13. Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis.
Lizcano-Meneses A; Watanabe N; von Glehn F; Barbosa R; de Albuquerque M; Yassuda C; Moraes AS; Martínez JW; Santos LMB; Cendes F
Seizure; 2021 Aug; 90():117-122. PubMed ID: 33658153
[TBL] [Abstract][Full Text] [Related]
14. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
[TBL] [Abstract][Full Text] [Related]
15. Sleep disorders in autoimmune encephalitis.
Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J
Lancet Neurol; 2020 Dec; 19(12):1010-1022. PubMed ID: 33212053
[TBL] [Abstract][Full Text] [Related]
16. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
17. Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
McWilliam O; Gramkow MH; Blaabjerg M; Clemmensen FK; Hasselbalch SG; Frederiksen KS
J Neurol; 2024 Apr; 271(4):1707-1716. PubMed ID: 38195895
[TBL] [Abstract][Full Text] [Related]
18. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
Gövert F; Abrante L; Becktepe J; Balint B; Ganos C; Hofstadt-van Oy U; Krogias C; Varley J; Irani SR; Paneva S; Titulaer MJ; de Vries JM; Boon AJW; Schreurs MWJ; Joubert B; Honnorat J; Vogrig A; Ariño H; Sabater L; Dalmau J; Scotton S; Jacob S; Melzer N; Bien CG; Geis C; Lewerenz J; Prüss H; Wandinger KP; Deuschl G; Leypoldt F
Brain; 2023 Feb; 146(2):657-667. PubMed ID: 35875984
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative Disorders and Sleep.
Malhotra RK
Sleep Med Clin; 2018 Mar; 13(1):63-70. PubMed ID: 29412984
[TBL] [Abstract][Full Text] [Related]
20. Objective sleep profile in LGI1/CASPR2 autoimmunity.
Devine MF; Feemster JC; Lieske EA; McCarter SJ; Sandness DJ; Steele T; Timm PC; Mandrekar J; Boeve BF; Silber MH; Dubey D; McKeon A; St Louis EK
Sleep; 2022 Feb; 45(2):. PubMed ID: 34953167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
